1. In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis
- Author
-
Constantinos G Missouris, Amit K J Mandal, Jason Kho, Adam Ioannou, and Koenraad Van den Abbeele
- Subjects
Pathology ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Pulmonary Artery ,Article ,Immune system ,medicine.artery ,Medicine ,Humans ,Pneumonitis ,business.industry ,SARS-CoV-2 ,Pulmonary embolism ,Pulmonary artery thrombosis ,COVID-19 ,Thrombosis ,Pneumonia ,Hematology ,medicine.disease ,Coronavirus ,D-dimer ,Pulmonary artery ,business - Abstract
Background Coronavirus disease 2019 (COVID-19) is characterised by dyspnoea and abnormal coagulation parameters, including raised D-dimer. Data suggests a high incidence of pulmonary embolism (PE) in ventilated patients with COVID-19. Objectives To determine the incidence of PE in hospitalised patients with COVID-19 and the diagnostic yield of Computer Tomography Pulmonary Angiography (CTPA) for PE. We also examined the utility of D-dimer and conventional pre-test probability for diagnosis of PE in COVID-19. Patients/methods Retrospective review of single-centre data of all CTPA studies in patients with suspected or confirmed COVID-19 identified from Electronic Patient Records (EPR). Results There were 1477 patients admitted with COVID-19 and 214 CTPA scans performed, of which n = 180 (84%) were requested outside of critical care. The diagnostic yield for PE was 37%. The overall proportion of PE in patients with COVID-19 was 5.4%. The proportions with Wells score of ≥4 (‘PE likely’) was 33/134 (25%) without PE vs 20/80 (25%) with PE (P = 0.951). The median National Early Warning-2 (NEWS2) score (illness severity) was 5 (interquartile range [IQR] 3–9) in PE group vs 4 (IQR 2–7) in those without PE (P = 0.133). D-dimer was higher in PE (median 8000 ng/mL; IQR 4665–8000 ng/mL) than non-PE (2060 ng/mL, IQR 1210–4410 ng/mL, P, Highlights • COVID-19 is associated with a higher rate of PE, particularly in critically-ill patients • Identifying those requiring PE imaging is challenging due to overlapping clinical presentation and high D-dimer in COVID-19 • Single-centre study of imaging outcomes (for PE), in patients with suspected/confirmed COVID-19 • 37% of inpatients scanned had PE. D-dimer >4200 ng/mL risk stratified, but could not exclude PE. • Clinicians should have high index of suspicion for PE in COVID-19
- Published
- 2021
- Full Text
- View/download PDF